Branko Cuglievan

8PUBLICATIONS
61CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)Radiation therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|Mar 12, 2026
Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

|Jun 09, 2025
Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma.

Kelsey L Corrigan, Amy M Berkman, Jillian Gunther

|Apr 14, 2025
Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras.

Vivek Subbiah, Megan Othus, Jim Palma

|Feb 24, 2025
Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia.

Olayinka Okeleji, David McCall, Amber Gibson

|Jan 27, 2025
Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncology.

Branko Cuglievan, Vivek Subbiah

Pageof 2

Frequent Collaborators

4 joint publications

David McCall

3 joint publications

Hagop M Kantarjian

3 joint publications

Courtney D DiNardo

3 joint publications

Tapan M Kadia